Here’s a look at the companies making headlines in midday trading: Intel — The struggling chip stock bounced back at the end of the year, rising nearly 1.2% in midday trading. Intel’s stock price plummeted more than 60% in 2024, putting the stock on track for its worst year ever and becoming the second-worst performer in the S&P 500. Shares of Nvidia, the artificial intelligence giant and retail investor favorite, fell 1.3% as traders took profits at the end of the trading year. Nvidia is up more than 170% and is on track to be the third-best performer in the S&P 500 in 2024. Shares of the company plummeted 54% over its hemophilia A gene therapy. Biohaven — The biopharmaceutical stock rose nearly 2% after director John Childs disclosed buying 29,000 shares. Childs currently owns about 6.5 million shares. Nutriband — Nutriband said it expects an expedited review process for its abuse-deterrent opioid patch called AVERSA Fentanyl, which could allow the company to win regulatory approval by the end of 2025. Shares rose more than 8% as the company extended its Chinese patent for the technology to Macau. Zivo Bioscience — Shares of Zivo Bioscience rose nearly 3% after investor Mark Strome, who owns 10% of the biotech company, purchased 75,000 shares. —CNBC’s Sean Conlon, Yun Li and Pia Singh contributed reporting.
ABOUT US
Our news website delivers comprehensive coverage on US news, economy, politics, and world events, ensuring you stay informed on the latest developments. We provide timely and accurate news to keep you updated on the most important stories. Stay connected with us for in-depth analysis and breaking news from around the globe.
Contact us: contact@realtimeheadlines.com
© Real Times Headlines - 2024 | All Rights Reserved